April 10, 2025 - 02:27

Two prominent healthcare organizations are making significant investments in generative AI technology to enhance the delivery of patient care and improve overall health outcomes. Highmark Health and Hackensack Meridian Health are at the forefront of this initiative, aiming to leverage advanced artificial intelligence tools to streamline operations and personalize patient experiences.
By integrating generative AI into their systems, these providers hope to reduce administrative burdens, allowing healthcare professionals to focus more on patient interactions and clinical decision-making. This technology has the potential to analyze vast amounts of data, enabling more accurate diagnoses and tailored treatment plans.
Furthermore, the adoption of GenAI can lead to improved patient engagement through interactive tools and resources that empower individuals to take an active role in their health management. As these healthcare giants explore the capabilities of generative AI, the industry is watching closely to see how this innovation will reshape the future of patient care and potentially set new standards for healthcare delivery.
February 2, 2026 - 18:41
This global health leader praises Trump's aid plan -- and gears up to beat malariaBill Steiger, a seasoned figure with senior roles in both the George H.W. Bush and Trump administrations, is now leading the charge against one of the world`s oldest diseases. As the new head of...
February 2, 2026 - 11:57
Letters: Claims using data about environment and health should be viewed skepticallyA recent online resource presenting parish-level health statistics has sparked debate by suggesting that public concerns over Louisiana`s industrial corridor may be exaggerated. The site utilizes...
February 1, 2026 - 21:40
Lou Holtz's son shares health update after college football coaching legend enters hospice careSkip Holtz, son of iconic college football coach Lou Holtz, provided a brief statement regarding his father`s condition on Sunday. The update comes as the elder Holtz, 87, receives hospice...
February 1, 2026 - 14:47
Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficiency Disorder in Mainland ChinaSHANGHAI, February 01, 2026--A new strategic collaboration has been formed between Tenacia Biopharmaceuticals and Golden Age Health (GAH) to commercialize the therapy ZTALMY® in mainland China....